BioHealth Innovation

MIMETAS appoints Todd Chappell general manager, U.S. Affairs

Tuesday, January 7, 2014

BioHealth Innovation (BHI) and MIMETAS, a developer of organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models, have announced Todd Chappell, MBA, an entrepreneur-in-residence for BHI, has been named general manager, U.S. Affairs for MIMETAS. A Netherlands-based company, MIMETAS is establishing its offices within BHI’s headquarters in Rockville, Md. MIMETAS and BHI created a U.S. subsidiary of MIMETAS to access the clinical, regulatory and scientific resources available in Central Maryland and to access the U.S. marketplace, the largest life sciences market in the world.

[Read More]